EUVIMEDEUVIMED entdecken
Crossref

Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells

Ying-Tao Zhong, Zi-Wen Qiu, Ke-Yan Zhang, Zhen-Ming Lu, Zhuo-Feng Li, Yi Cen, Shi-Ying Li, Hong Cheng iD

Advanced Materials · 2025-04 · 37 (13)

DOI: 10.1002/adma.202415078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.02.2025. Verfasst von Ying-Tao Zhong und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering & Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Southern Medical Universi…. Hauptthemen laut MEDLINE: Pyroptosis, Photochemotherapy, Cell Membrane, B-Lymphocytes. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade (ICB) therapy has achieved remarkable benefits in the treatment of malignant tumors, but the clinical response rates are unsatisfied due to the low tumor immunogenicity and the abundant immunosuppressive cells. Herein, a plasma membrane targeted photodynamic nanoagonist (designated as PMTPN) is developed to potentiate ICB therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells. PMTPN is composed of a rationally designed chimeric peptide sequence loaded with Bruton's tyrosine kinase inhibitor (Ibrutinib). Notably, PMTPN is capable of sequentially targeting tumor and tumor cell membrane to trigger immunogenic pyroptosis and cause overwhelming release of cytokines, promoting dendritic cells maturation, and cytotoxic T lymphocytes (CTLs) activation. Meanwhile, PMTPN can also deplete infiltrating B cells and reduce the secretion of interleukin‐10 to decrease immunosuppressive regulatory T cells and enhance CTLs infiltration. Beneficially, the synergistic immune modulating characteristics of PMTPN potentiate ICB therapy to simultaneously eliminate primary and distant tumors. This study offers a promising strategy to elevate the immunotherapeutic response rate in consideration of the complex immunosuppressive factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisPhotochemotherapyCell MembraneB-LymphocytesImmune Checkpoint InhibitorsPhotosensitizing AgentsNanoparticlesHumansAnimalsMiceCell Line, TumorT-Lymphocytes, CytotoxicNeoplasms

Stichwörter der Autor:innen

drug deliveryimmune checkpoint blockadeimmunosuppressioninfiltrating B cellspyroptosis

Substanzen

Immune Checkpoint InhibitorsPhotosensitizing Agents

Autor:innen und Institutionen

  • School of Biomedical Engineering & Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Southern Medical University, Guangzhou, 510515, China.
  • The Fifth Affiliated Hospital, Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou,…

ORCID-Profile: Hong Cheng

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhong, Y. T., Qiu, Z. W., Zhang, K. Y., Lu, Z. M., Li, Z. F., Cen, Y., Li, S. Y., & Cheng, H. (2025). Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells. Advanced Materials, 37(13). https://doi.org/10.1002/adma.202415078

Vancouver

Zhong YT, Qiu ZW, Zhang KY, Lu ZM, Li ZF, Cen Y, et al. Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells. Advanced Materials. 2025;37(13). doi:10.1002/adma.202415078

BibTeX
@article{Zhong2025,
  author = {Zhong, Ying-Tao and Qiu, Zi-Wen and Zhang, Ke-Yan and Lu, Zhen-Ming and Li, Zhuo-Feng and Cen, Yi and Li, Shi-Ying and Cheng, Hong},
  title = {Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {13},
  doi = {10.1002/adma.202415078}
}
Kostenlos starten →